AI CRO vs A/B testing

What is the difference between AI CRO and A/B testing?

A/B test: a human forms a hypothesis, builds two versions, splits traffic, and reads the result weeks later. AI CRO: software reads a live session, decides what that particular visitor needs, and acts — then measures the whole of its behaviour against a held-back group.

The row that decides most real outcomes is the last one. A testing programme is only as good as the attention it receives, and attention is the resource every team runs out of first. The common failure of A/B testing in practice is not an inconclusive test; it is a tool nobody has opened since spring.

Where is A/B testing still the better tool?

Whenever you have one specific change worth proving, and you need a number you can defend. A test isolates a single variable and produces an answer with a confidence interval attached — which no continuously-acting system gives you as cleanly.

Where does AI CRO do better?

In the space between tests — the hundred small moments per day nobody has a hypothesis for. It also escapes the traffic floor that stops low-volume sites from testing at all, because a decision per visitor does not need a variation to reach significance.

A test applies one answer to everyone in a group. That is what makes its result readable, and it is also why a change that helps hesitant visitors while irritating decided ones can measure as no effect at all: the two cancel. A per-visitor decision does not average them, because it never treated them the same way.

The second advantage is cadence. A test cycle is measured in weeks and consumes a person for part of that time. A loop that runs on its own accumulates evidence continuously, and — crucially — keeps running during the months when the team is busy shipping something else.

The third is memory. A testing programme's learning lives in the heads of the people who ran it, and leaves when they do. A system that records which moment, which format and which message converted on this specific site is building an asset instead of a slide deck.

Do they measure the same thing?

Both compare a treated group with an untreated one, which is what makes either trustworthy. They differ in duration and scope: a test's control exists for that test and covers one change, while a holdout is permanent and covers everything the system does.

This matters more than it sounds. A system that acts continuously and changes its own behaviour cannot be evaluated by a test that ended in March. Its control has to run for as long as it does, or the number stops describing the system that is currently live.

The failure to watch for is a vendor comparing visitors who received an intervention against visitors who did not, without random assignment. Those groups differ in precisely the way that caused the intervention — the software chose them — so the gap measures its selection at least as much as its help. It is the easiest chart to produce and the most flattering, which is why it is common.

The question worth asking either kind of vendor is the same: what were the two groups, and who decided who went in which.

Can you use both?

Yes, and they interfere less than expected — they operate at different levels. Testing decides what the page fundamentally is; an agent works within whatever the page currently is. Keep the agent's holdout out of any test's variant assignment and the two measurements stay clean.

In practice the division tends to settle on its own. Structural questions — what to offer, how to price it, how the flow is arranged — go to tests, because they are big, occasional and worth arguing about. The continuous, per-visitor layer goes to the agent, because nobody was ever going to run three hundred tests a year on it.

Where Cromanion sits

Cromanion is on the AI CRO side of this comparison, and it takes the measurement problem seriously: 10% of sessions are held back permanently, on every plan including the free one, and every decision is recorded with its control or exposed assignment.

It does not replace a testing tool and does not try to. It runs in the space a testing programme cannot reach — per visitor, continuously — and it reports what it caused in the same terms a test would: a treated group, a randomly assigned untreated group, and the difference between them.

The results are written into the analytics the owner already runs rather than kept in a dashboard of ours, which is the same instinct: a number you can check against a tool we do not control is worth more than a number we present nicely.